David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CFXA
501
DELISTED
Colfax Corporation 5.75% Tangible Equity Units
CFXA
| $32.7M | 0.04% |
+245,000
| New | +$29.7M |
|
|
KL
502
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $32.4M | 0.04% |
1,063,779
+81,499
| +8% | +$2.58M |
|
503
Navient
NAVI
$888M
| $32.3M | 0.04% |
2,791,886
-1,254,582
| -31% | -$14.4M |
|
504
United Therapeutics
UTHR
$22B
| $32.3M | 0.04% |
275,073
-162,003
| -37% | -$18.9M |
|
|
SEE
505
DELISTED
Sealed Air
SEE
| $32.2M | 0.04% |
698,039
-286,187
| -29% | -$11.9M |
|
506
TC Energy
TRP
$64.7B
| $32.1M | 0.04% |
714,913
-1,102,020
| -61% | -$47.4M |
|
|
EVBG
507
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $32.1M | 0.04% |
427,930
+352,902
| +470% | +$23M |
|
|
DYNC
508
DELISTED
Vistra Energy Corp.
DYNC
| $32.1M | 0.04% |
+325,000
| New | +$31.6M |
|
509
Evergy
EVRG
$18.8B
| $32M | 0.04% |
550,941
-110,751
| -17% | -$6.3M |
|
|
ZEN
510
DELISTED
ZENDESK INC
ZEN
| $31.8M | 0.04% |
374,592
-164,927
| -31% | -$12.1M |
|
511
Autodesk
ADSK
$53.7B
| $31.7M | 0.04% |
203,174
+4,050
| +2% | +$605K |
|
512
NovoCure
NVCR
$1.95B
| $31.6M | 0.04% |
656,881
+614,012
| +1,432% | +$29.6M |
|
|
THS
513
DELISTED
Treehouse Foods
THS
| $31.6M | 0.04% |
489,375
+179,057
| +58% | +$10.6M |
|
514
BHP
BHP
$247B
| $31.4M | 0.04% |
644,381
-822,148
| -56% | -$37.5M |
|
|
MNTA
515
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $31.2M | 0.04% |
2,148,849
-449,793
| -17% | -$5.74M |
|
|
CATM
516
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $31.2M | 0.04% |
876,174
+174,919
| +25% | +$5.21M |
|
517
DNOW Inc
DNOW
$2.8B
| $31.1M | 0.04% |
2,226,959
-42,164
| -2% | -$586K |
|
518
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.6B
| $31M | 0.04% |
+358,998
| New | +$30.5M |
|
519
Fox Class A
FOXA
$29B
| $31M | 0.04% |
+845,467
| New | +$32.9M |
|
520
PUT
Lam Research
LRCX
$388B
| $30.8M | 0.04% |
1,719,000
-2,017,000
| -54% | -$33.7M |
|
|
MASI
521
DELISTED
Masimo
MASI
| $30.7M | 0.04% |
222,248
-55,741
| -20% | -$7M |
|
|
ZIONW
522
DELISTED
Zions Bancorporation N.A. Warrants
ZIONW
| $30.6M | 0.04% |
2,308,700
| – | – |
|
523
HubSpot
HUBS
$12.2B
| $30.6M | 0.04% |
183,809
+150,623
| +454% | +$23.9M |
|
524
NextEra Energy
NEE
$175B
| $30.5M | 0.04% |
630,760
-345,080
| -35% | -$15.8M |
|
525
Ascendis Pharma A/S
ASND
$16.5B
| $30.4M | 0.04% |
258,177
+211,996
| +459% | +$18.6M |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.